more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$87.10 USD

+0.90 (1.04%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $87.11 +0.01 (0.01%) 4:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

Top 27% (69 out of 251)

Industry: Medical - Products

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Boston Scientific Gets a Boost From MedSurg Arm Amid Coronavirus

by Zacks Equity Research Published on October 14,2020

Within Endoscopy, Boston Scientific (BSX) believes that business recovery started since June.

medical

3 Best MedTech Value Stocks to Buy Ahead of Q3 Earnings

by Sriparna Ghosal Published on October 14,2020

These three MedTech stocks are expected to grow post their Q3 earnings release.

medical

Here's Why You Should Hold on to Nevro (NVRO) Stock Now

by Zacks Equity Research Published on October 14,2020

Nevro (NVRO) continues to gain traction from its flagship platform, Senza, and R&D capabilities. However, stiff competition remains a woe.

medical

Abbott's New Antibody Test Gets FDA's EUA, Test Suite Expands

by Zacks Equity Research Published on October 13,2020

Abbott's (ABT) latest antibody test is expected to give a clearer picture of the rate of recovery post coronavirus infection.

medical

Here's Why You Should Add AngioDynamics to Your Portfolio Now

by Zacks Equity Research Published on October 13,2020

Investor confidence is high in AngioDynamics (ANGO) stock, thanks to solid prospects.

medical

Here's Why You Should Hold on to NuVasive (NUVA) Stock Now

by Zacks Equity Research Published on October 13,2020

Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently-launched products as well as potential in its U.S. Surgical Support business.

medical

Here's Why You Should Hold on to Stryker (SYK) Stock Now

by Zacks Equity Research Published on October 13,2020

Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.

medical

Bruker Rides on Nano and MALDI Launches Despite Margin Debacle

by Zacks Equity Research Published on October 12,2020

Bruker (BRKR) has several Bruker NANO products that are being assembled and tested in Malaysia.

medical

Abbott's Data From Interim Clinical Study of ID NOW Positive

by Zacks Equity Research Published on October 12,2020

Abbott's (ABT) recent data from an interim clinical study on its ID NOW COVID-19 rapid test reflects the test's capacity to deliver effective, consistent and reliable performance.

medical

Veeva Develops 2 Applications on Veeva Clinical Network (Revised)

by Zacks Equity Research Published on October 12,2020

This should boost Veeva's (VEEV) portfolio of cloud-based offerings for the life sciences industry.

medical

Bio-Rad (BIO) Hits a New 52-Week High: What's Driving It?

by Zacks Equity Research Published on October 12,2020

Bio-Rad (BIO) is optimistic about maintaining robust testing portfolio along with strength in its Life Sciences business.

Ecolab Introduces New Automated Precision Dispensing System

by Zacks Equity Research Published on October 09,2020

Ecolab's (ECL) newly launched Precision Dispensing System for Membranes can drive productivity and boost worker safety.

medical

Pacific Biosciences Unveils Sequel IIe for HiFi Sequencing

by Zacks Equity Research Published on October 08,2020

Pacific Biosciences' (PACB) recently-launched Sequel IIe System is powered by its SMRT technology.

Masimo Unveils New Wearable Wireless Continuous Thermometer

by Zacks Equity Research Published on October 08,2020

Masimo's (MASI) wearable wireless continuous thermometer offers consumers hassle-free continuous body temperature measurements, thereby eliminating the need for manual measurements.

Ecolab Disinfectant Gets EPA Nod for Use Against SARS-CoV-2

by Zacks Equity Research Published on October 07,2020

Ecolab's (ECL) Peroxide Multi Surface Cleaner and Disinfectant is the first EPA-registered disinfectant proven to be effective at killing the SARS-CoV-2 virus.

medical

Ecolab Launches Sanitizer to Prevent Food-Borne Illness

by Zacks Equity Research Published on October 06,2020

Ecolab's (ECL) Sink & Surface Cleaner Sanitizer is the first EPA-registered product for use against norovirus and SARS-CoV-2.

medical

Here's Why You Should Retain Fresenius Medical Stock Now

by Zacks Equity Research Published on October 06,2020

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

medical

BD Gets 510(k) Clearance for Its FACSLyric Flow Cytometer

by Zacks Equity Research Published on October 06,2020

BD (BDX) gets 510(k) clearance from the FDA for its new integrated system that helps clinical laboratories to fully automate the sample to answer process and boost their efficiency.

medical

Boston Scientific, Farapulse Sign Deal for Treatment of AF

by Zacks Equity Research Published on September 25,2020

Boston Scientific (BSX) aims to provide a comprehensive portfolio of electrophysiology products and services via the latest investment agreement.

medical

Boston Scientific Launches DBS System in Europe Post Approval

by Zacks Equity Research Published on September 15,2020

Boston Scientific (BSX) aims to optimize therapy outcomes via the fourth-generation Vercise Genus DBS System's post-regulatory clearance in Europe.

medical

Here's Why You Should Hold on to Medtronic Stock for Now

by Zacks Equity Research Published on September 14,2020

Investors continue to be optimistic about Medtronic (MDT) on robust segmental growth and strong ventilators sales.

medical

Boston Scientific's Eluvia Gets CMS' Additional Reimbursement

by Zacks Equity Research Published on September 04,2020

Boston Scientific (BSX) gains CMS' NTAP designation for its Eluvia stent system, thus providing additional reimbursement to Medicare beneficiaries suffering from PAD.

medical